Compare JPMorgan Chase & Co (JPM) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Chase & Co vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? JPMorgan Chase & Co trades at $331.82 (market cap $876.09B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: JPMorgan Chase & Co is far larger — about 384.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and JPMorgan Chase & Co pays a 2% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| JPM | SLS | |
|---|---|---|
Market Cap | $876.09B | $2.28B |
Volume | 6,651,143 | 3,128,960 |
Sector | Financials | Health |
52-Week High | $365.18 | $15.46 |
52-Week Low | $282.84 | $1.39 |
Typical Hold Time | 127 Days | — |
Enterprise Value | $1.81T | $2.15B |
Dividend Yield | 2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPMorgan Chase trades at $331.42, up 0.04% with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 EPS of $7.59, beating expectations by 36%, with revenue reaching $181.85B in 2025. Analyst consensus remains positive with a $373.18 price target and 52% buy ratings, though technical indicators show selling pressure with RSI levels suggesting potential oversold conditions near key support at $323.
JPMorgan demonstrates robust profitability with 18.43% ROE and reasonable valuation at 14.12 P/E, but faces risks from geopolitical tensions and cybersecurity threats. The stock offers upside to analyst targets with strong institutional support, though negative cash flow trends and bearish technical momentum warrant caution amid macroeconomic uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
